“If you want your stocking stuffed on Christmas, go ahead.” — Justin Dubin, MD, a urologist in South Florida, reassuring couples after a new study found penile fractures spike around Christmas Day.
“There’s still a long road ahead to having it as a legal, accepted, and accessible treatment for this.” — Nehal Vadhan, PhD, of Northwell Health in New York, commenting on psilocybin for treating cancer patients’ depression.
“When corporations interfere with the scientific process, it puts patients at risk.” — Adrian Traeger, PhD, of the University of Sydney in Australia, discussing the role of industry-funded critics in spinal cord stimulation research.
“We must be thoughtful about how to carefully integrate AI into clinical workflows.” — Sarah Jabbour, MSE, of the University of Michigan in Ann Arbor, on the impact of AI in the diagnosis of hospitalized patients.
“The main ‘aha’ moment for me was the realization that the toll of disease and disability is larger in the post-acute phase than the acute phase of illness.” — Ziyad Al-Aly, MD, of Washington University in St. Louis, comparing long flu with long COVID.
“To say what comes first … is still an open question.” — Daniel Waintraub, MD, of Gastro Health Boca Raton in Florida, on the link between appendectomy and Crohn’s disease.
“Why can’t Dr. Barbie do anything to help her?” — Katherine Klamer, of Indiana University in Indianapolis, after finding most of the 80 Barbie medical professional dolls treat kids.
“Most children don’t care at all whether they can brush their hair or their teeth.” — Carolina Barnett-Tapia, MD, PhD, of the University of Toronto, on why children-specific measures are needed for juvenile generalized myasthenia gravis.
Please enable JavaScript to view the